Pharma Deals Review Latest Articles

• Amphista Enters Protein Degradation Collaborations with Bristol-Myers Squibb and Merck Published: 26 May-2022
  By: Lucy Haggerty
  Abstract Fulltext:
  Volume: 2022 Issue: 5
• Pfizer Buys Biohaven for US$11.6 B Published: 13 May-2022
  By: Lucy Haggerty
  Abstract Fulltext:
  Volume: 2022 Issue: 5
• Jazz Licenses Sumitomo’s Narcolepsy Drug for US$50 M Upfront Published: 7 May-2022
  By: Lucy Haggerty
  Abstract Fulltext:
  Volume: 2022 Issue: 5
• Caladrius and Cend Merge to Become Lisata Therapeutics Published: 30 Apr-2022
  By: Lucy Haggerty
  Abstract Fulltext:
  Volume: 2022 Issue: 4
• Regeneron Bolsters I-O Portfolio with US$250 M Checkmate Acquisition Published: 21 Apr-2022
  By: Lucy Haggerty
  Abstract Fulltext:
  Volume: 2022 Issue: 4